Human Recombinant Epidermal Growth Factor in skin lesions: 77 cases in EPItelizando Project.
- Authors:
- Jordi Esquirol-Caussa,
- Elisabeth Herrero-Vila
J Dermatolog Treat 2018 Apr 23:1-23. Epub 2018 Apr 23.
a Centro Médico Teknon , Barcelona , Spain.
Objective: To analyze compounded recombinant human Epidermal Growth Factor (rhEGF) effectiveness on skin lesions through a case series.
Design: Multicentric series of skin lesions treated with topical recombinant human Epidermal Growth Factor. SITE: Patients from 56 different health professionals, three different countries, two recruitment years. Read More
Design: Multicentric series of skin lesions treated with topical recombinant human Epidermal Growth Factor. SITE: Patients from 56 different health professionals, three different countries, two recruitment years. Read More